Pang-an, Eiem O.

HRN: 21-67-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
CEFUROXIME 1.5GM (VIAL)
09/21/2022
09/24/2022
IV
1.5g
Q8
Post Op Prophylaxis
Waiting Final Action 
09/22/2022
CEFUROXIME 500MG (TAB)
09/22/2022
09/29/2022
ORAL
500mg
BID
Post OP Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: